SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-366374
Filing Date
2021-12-23
Accepted
2021-12-23 17:26:32
Documents
15
Period of Report
2021-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d221389d8k.htm   iXBRL 8-K 29099
2 EX-5.1 d221389dex51.htm EX-5.1 8590
3 EX-10.1 d221389dex101.htm EX-10.1 182582
7 GRAPHIC g221389g78n03.jpg GRAPHIC 3445
  Complete submission text file 0001193125-21-366374.txt   400729

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crtx-20211223.xsd EX-101.SCH 2895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20211223_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20211223_pre.xml EX-101.PRE 10955
9 EXTRACTED XBRL INSTANCE DOCUMENT d221389d8k_htm.xml XML 3237
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 211518189
SIC: 2836 Biological Products, (No Diagnostic Substances)